| Literature DB >> 31057654 |
Yue Sun1, George Binh Lenon1, Angela Wei Hong Yang1.
Abstract
BACKGROUND: Phellodendri Cortex (PC) or Huang Bai. According to the scientific database of China Plant Species and Chinese pharmacopeia 2015 edition, PC has two main species which are Phellodendron amurense Rupr (PAR) or "Guan Huang bai" in Chinese and Phellodendron chinense Schneid (PCS) or "Chuan Huang bai" in Chinese. The crude drugs of PAR and PCS are also called Phellodendri amurensis cortex (PAC) and Phellodendri chinense cortex (PCC), respectively. The medicinal part of the plant is the dried trunk bark. PC has comprehensive therapeutic effects which include anti-inflammatory, antimicrobial, anticancer, hypotensive, antiarrhythmic, antioxidant, and antipyretic agents. The exact ingredients in PC and its species are not fully summarised. AIM OF THE STUDY: This study was designed to review and evaluate the pharmacological actions of compounds and to explore the pharmacokinetic knowledge of PC and its species and to also identify the chemical compound(s) with a potential therapeutic effect on atopic dermatitis.Entities:
Year: 2019 PMID: 31057654 PMCID: PMC6463642 DOI: 10.1155/2019/7621929
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1PC study selection flowchart.
Summary of chemical constituents isolated from PC and its different species (140 compounds).
| Compound derivatives | Chemical compounds | Methods | References | Original species |
|---|---|---|---|---|
| Alkaloid | Berberine | (i) UPLC-ESI-Q-TOF-MS | (i) [ | (i) PAC |
| (ii) HPLC-DAD-ESI-MS2 | (ii) [ | (ii) PCS and PAR | ||
| (iii) UPLC-Q/TOF-HDMS | (iii) [ | (iii) PAC | ||
| (iv) HPLC-TLC- NMR-EI-MS | (iv) [ | (iv) PAR | ||
| (v) HPLC-DAD-MS | (v) [ | (v) PAR | ||
| (vi) N/A | (vi) [ | (vi) PAC and PCS | ||
| 8,13-dioxo-14-butoxycanadine | CC | [ | PCS | |
| Berberrubine | UPLC-ESI-Q-TOF-MS | [ | PAC | |
| Berberastine | UPLC-Q/TOF-HDMS | [ | PAC | |
| Bis-[4-(dimethylamino)phenyl]methanone | HPLC-ESI-MS/MS | [ | PAR | |
| Brucine | CE | [ | PCS | |
| Δ7-dehydrosophoramine | N/A | [ | PAC | |
| Dihydrocyclobuxine-D | HPLC-ESI-MS/MS | [ | PAR | |
| 3,4-dihydro-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-8-isoquinolinol | HPLC-ESI-MS/MS | [ | PAR | |
| 3,4-dihydro-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-6-isoquinolinol | HPLC-ESI-MS/MS | [ | PAR | |
| 7,8-dihydroxyrutaecarpine | HPLC-ESI-MS/MS | [ | PAR | |
| 4-dimethylamino-4 -isopropylbenzene | HPLC-ESI-MS/MS | [ | PAR | |
| Evodiamine | HPLC-ESI-MS/MS | [ | PAR | |
| Palmatine | (i) UPLC-ESI-Q-TOF-MS | (i) [ | (i) PAC | |
| (ii) HPLC-DAD-ESI-MS2 | (ii) [ | (ii) PCS and PAR | ||
| (iii) UPLC-Q/TOF-HDMS | (iii) [ | (iii) PCC | ||
| (iv) HPLC-DAD-MS | (iv) [ | (iv) PAR | ||
| (v) N/A | (v) [ | (v) PCS | ||
| Tetrahydropalmatine | UPLC-ESI-Q-TOF-MS | [ | PAC | |
| Tetrahydroberberine | HPLC-ESI-MS/MS | [ | PAR | |
| Phellodendrine | (i) UPLC-ESI-Q-TOF-MS | (i) [ | (i) PAC | |
| (ii) HPLC-DAD-ESI-MS2 | (ii) [ | (ii) PCS and PAR | ||
| (iii) UPLC-Q/TOF-HDMS | (iii) [ | (iii) PAC | ||
| (iv) HPLC-DAD-MS | (iv) [ | (iv) PAR | ||
| (v) N/A | (v) [ | (v) PAC and PCS | ||
| Magnocurarine | (i) HPLC-ESI-MS/MS | (i) [ | (i) PAR | |
| Magnoflorine | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| (iii) HPLC-DAD-MS | (iii) [ | (iii) PAR | ||
| (iv) N/A | (iv) [ | (iv) PCS | ||
| Jatrorrhizine or Neprotin, 2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol | (i) UPLC-ESI-Q-TOF-MS | (i) [ | (i) PAC | |
| (ii) HPLC-DAD-ESI-MS2 | (ii) [ | (ii) PCS and PAR | ||
| (iii) HPLC-DAD-MS | (iii) [ | (iii) PAR | ||
| (iv) N/A | (iv) [ | (iv) PAC | ||
| 13-methoxyjatrorrhizine | HPLC-ESI-MS/MS | [ | PAR | |
|
| CC | [ | PAR | |
| Canthin-6-one | CC | [ | PAR | |
| 4-methoxy-N-methyl-2-quinolone | CC | [ | PAR | |
| Oxypalmatine | CC | [ | PAR | |
| Candicine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Lotusine | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PAC | ||
| N-methylhigenamine-7-O-glucopyranoside | HPLC-ESI-MS/MS | [ | PAR | |
| N-methylhigenamine-7-O- | HPLC-DAD-ESI-MS2 | [ | PAR | |
| (−)-Oblongine | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| Isomer-of-berberine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Isomer-of-magnoflorine | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| Isomer-of-palmatine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Tetrahydroreticuline | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Tetrahydrojatrorrhizine | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| Menisperine | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| (iii) N/A | (iii) [ | (iii) PAC | ||
| (+) N-methylcorydine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| N-methyl Tetrahydropalmatine | HPLC-ESI-MS/MS | [ | PAR | |
| N-methylflindersine | HPLC-ESI-MS/MS | [ | PAR | |
| Litcubine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Hydroxyl-palmatine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| 11-hydroxylpalmatine | HPLC-ESI-MS/MS | [ | PAR | |
| 13-hydroxypalmatine | HPLC-ESI-MS/MS | [ | PAR | |
| 7-hydroxy-8-methoxydedihydrorutaecarpine | HPLC-ESI-MS/MS | [ | PAR | |
| Tetrahydropalmatine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Xanthoplanine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| N-methylphoebine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Columbamine | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| Dihydroxyl-jatrorrhizine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Epiberberine | HPLC-DAD-ESI-MS2 | [ | PAR | |
| (6aS)-1,2,10,11-tetramethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g] quinolinium | UPLC-Q/TOF-HDMS | [ | PCC | |
| Dasycarpamin | UPLC-Q/TOF-HDMS | [ | PCC | |
| Pteleine | HPLC-UV | [ | PAR | |
| (-)-(R)-platydesmin | HPLC-UV | [ | PAR | |
| Noroxyhydrastinine | HPLC-UV | [ | PAR | |
| Chilenine | HPLC-UV | [ | PAR | |
| Rutecarpine | HPLC-ESI-MS/MS | [ | PAR | |
| Skimmianine | HPLC-ESI-MS/MS | [ | PAR | |
| Tembetarine | HPLC-ESI-MS/MS | [ | PAR | |
| Tetramethyl-O-scutellarin | UPLC-Q/TOF-HDMS | [ | PCC | |
| 5,8,13,13a-Tetrahydro-2,9,10,11-tetrahydroxy-3-methoxy-7-methyl-6H-dibenzo[a,g]quinolizinium | HPLC-ESI-MS/MS | [ | PAR | |
|
| UPLC-Q/TOF-HDMS | [ | PCC | |
|
| ||||
| Isoquinoline alkaloid | Armepavine | UPLC-ESI-Q-TOF-MS | [ | PAC |
| Demethyleneberberine | UPLC-ESI-Q-TOF-MS | [ | PAC | |
| 8-oxoberberine | HPLC-ESI-MS/MS | [ | PAR | |
| 8-oxoepiberberine | HPLC-ESI-MS/MS | [ | PAR | |
| 8-oxopalmatine | HPLC-ESI-MS/MS | [ | PAR | |
| Oxyberberine | HPLC | [ | PAR | |
| Oxypalmatine | HPLC | [ | PAR | |
|
| ||||
| Limonoid | Kihadanin B | N/A | [ | PAC |
| Niloticin | N/A | [ | PAC | |
| Niloticin acetate | N/A | [ | PCS | |
| Obaculactone or limonin | (i) UPLC-ESI-Q-TOF-MS | (i) [ | (i) PAC | |
| (ii) CC | (ii) [ | (ii) PAR | ||
| (iii) UPLC-Q/TOF-HDMS | (iii) [ | (iii) PCC | ||
| (iv) HPLC-TLC- NMR- EI-MS | (iv) [ | (iv) PAC | ||
| (v) N/A | (v) [ | (v) PAC | ||
| Derivative of obaculactone | UPLC-Q/TOF-HDMS | [ | PCC | |
| Obacunone or Obacunoic acid | (i) CC | (i) [ | (i) PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| (iii) HPLC-TLC- NMR- EI-MS | (iii) [ | (iii) PAC | ||
| (iv) HPLC-DAD-ESI-MS2 | (iv) [ | (iv) PAR | ||
| (v) N/A | (v) [ | (v) PAC | ||
| 12 | CC | [ | PAR | |
| Piscidinol A | N/A | [ | (i) PCS | |
| Rutaevin | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| Coniferin | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Vanilloloside | HPLC-DAD-ESI-MS2 | [ | PAR | |
| N-methyltetrahydrocolumbamine | UPLC-Q/TOF-HDMS | [ | PCC | |
|
| ||||
| N-acyl amines | Herculin | N/A | [ | PAC |
|
| ||||
| Phenolic acid | Ferulic acid | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR |
| (ii) HPLC-TLC- NMR- EI-MS | (ii) [ | (ii) PAC | ||
| Methyl ferulate | CC | [ | PCS | |
| Protocatechuic acid | CC | [ | PCS | |
|
| ||||
| Quinic acid | Quinic acid | UPLC-Q/TOF-HDMS | [ | PAC |
| Neo-chlorogenic acid | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| 3-O-feruloylquinic acid | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PAC | ||
| 3-O-feruloylquinic acid glucoside | UPLC-Q/TOF-HDMS | [ | PCC | |
| 4-O-feruloylquinic acid | HPLC | [ | PCS | |
| 5-O-feruloylquinic acid | HPLC | [ | PCS | |
| Chlorogenic acid | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PAC | ||
| (iii) HPLC | (iii) [ | (iii) PAR | ||
| (iv) HPLC-DAD-MS | (iv) [ | (iv) PAR | ||
| Methyl 3- | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Methyl 5-O-feruloylquinate | NMR | [ | PAR | |
| 3-Feruoyl-4-caffeoylquinic acid | HPLC-DAD-ESI-MS2 | [ | PAR | |
| Sanleng acid | NMR | [ | PAC | |
|
| ||||
| Hydroxycinnamic acid | Caffeic Acid Methyl Ester | HPLC | [ | PCS |
|
| ||||
| Phytosterol |
| N/A | [ | PAC |
|
| ||||
| Lignan | (+/-)-lyoniresinol | HPLC-DAD-ESI-MS2 | [ | PAR |
| (+/-)-5,5′-dimethoxylariciresinol-4- | (i) HPLC-DAD-ESI-MS2 | (i) [ | (i) PCS and PAR | |
| (ii) UPLC-Q/TOF-HDMS | (ii) [ | (ii) PCC | ||
| Syringaresinol di-O- | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| (-)-Syringaresinol | CC | [ | PCS | |
|
| ||||
| Flavonoid | Amurensin | N/A | [ | PAC |
| Quercetin | HPLC-TLC- NMR- EI-MS | [ | PAC | |
| Phellamurin | N/A | [ | PAC | |
| Phellatin | N/A | [ | PAC | |
| Phellavin | N/A | [ | PAC | |
| Phellodendroside | N/A | [ | PAC | |
|
| UV | [ | PAR | |
| Icariside-1 | UV | [ | PAR | |
| Phellamuretin | UV | [ | PAR | |
| Phelloside | UV | [ | PAR | |
| Dihydrophelloside | UV | [ | PAR | |
| Isovaleric acid | UV | [ | PAR | |
| Kaempferol | UV | [ | PAR | |
| D-glucose | UV | [ | PAR | |
|
| ||||
| Rutaceae | Noricariside | N/A | [ | PAC |
|
| ||||
| Stigmastane | 7-Dehydrostigmasterol | N/A | [ | PAC |
|
| ||||
| Coumarin | 3-acetyl-3,4-dihydro-5,6-dimethoxy-1H-2-benzopyran-1-one | CC | [ | PCS |
|
| ||||
| Monosaccharide | Syringin | NMR | [ | PAC |
| Daucosterol | NMR | [ | PAC | |
|
| ||||
| Paraben | N-propyl paraben | HPLC | [ | PC |
|
| ||||
| Phenolic lactone | Phellolactone | CC | [ | PCS |
|
| ||||
| Ferulate | N-butyl Ferulate | CC | [ | PCS |
| Amurenlactone A | CC | [ | PCS | |
| Amurenamide A | NMR | [ | PAC | |
|
| ||||
| Hydroxybenzaldehyde | 4-hydroxybenzaldehyde | CC | [ | PCS |
|
| ||||
| Phenolic aldehyde | Vanillin | CC | [ | PCS |
|
| ||||
| Glycoside | Sinapyl aldehyde-4-O-beta-D-glucopyranoside | NMR | [ | PAR |
| 3,4,5-Trimetoxyphenol O- | HPLC | [ | PCS | |
| 2-methoxy-4-(2-propenyl)phenyl-beta-D-glucopyranoside | HPLC | [ | PCS | |
| 2-(p-hydroxyphenyl)-ethanol-1-O- | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
| 2-(p-hydroxyphenyl) -ethanol-1-O- | UPLC-Q/TOF-HDMS | [ | PCC | |
| 3, 5-dihydroxybenzoicacid-O-xylopyranosyl-glucopyranoside | HPLC-DAD-ESI-MS2 | [ | PCS and PAR | |
|
| ||||
| Phenolic glycoside | Tachioside | HPLC | [ | PCS |
|
| ||||
| Glucoside | Salidroside | HPLC | [ | PCS |
| 4-hydroxybenzyl alcohol | HPLC | [ | PCS | |
|
| ||||
| Phenol | Methyl syringate | HPLC | [ | PCS |
|
| ||||
| Dehydrovomifoliol | (6S)-dehydrovomifoliol | HPLC | [ | PCS |
| (6R,7aR)-epiloliolide | HPLC | [ | PCS | |
PAC: phellodendri amurensis cortex
PCS: phellodendron chinense schneid
PAR: phellodendron amurense rupr.
PCC: phellodendri Chinensis cortex
UPLC-ESI-Q-TOF-MS: ultra-performance liquid chromatography coupled with electrospray ionization/quadrupole-time-of-flight mass spectrometry
CC: column chromatography
CE: capillary electrophoresis
HPLC/MSD: high-performance liquid chromatography coupled with mass spectrometric detection
UPLC–Qthe -TOF-MS: ultra-performance liquid chromatography with quadrupole TOF-MS
HPLC– ESI-MS2: high-performance liquid chromatography with electrospray ionization mass spectrometry coupled with photodiode array detection
UPLC-Q/TOF-HDMS: ultra-performance liquid chromatography-quadrupole/time-of-flight high-definition mass spectrometry
UV: UV detection
EI-MS: Electron ionization mass spectrometry
NMR: Nuclear magnetic resonance
TLC: Thin-layer chromatography
HPLC-DAD-MS: high-performance liquid chromatography coupled with diode array detection and mass spectrometry
Molecular formula, molecular weight and chemical structures of compounds derived from PCC species (18 compounds).
| Compound derivatives | Compound | Molecular formula | Molecular weight | Chemical structures |
|---|---|---|---|---|
| Alkaloid | Palmatine | C21H22NO4+ | 352.41 g/mol |
|
| Magnoflorine | C20H24NO4+ | 342.41 g/mol |
| |
| (−)-Oblongine | C19H24NO3+ | 314.40 g/mol |
| |
| Menisperine | C21H26NO4+ | 356.44 g/mol |
| |
| (6aS)-1,2,10,11-tetramethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g] quinolinium | C22H28NO4 | 370.47 g/mol |
| |
| Dasycarpamin | C17H21NO4 | 303.36 g/mol |
| |
| Tetramethyl-O-scutellarin | C19H18O6 | 342.35 g/mol |
| |
|
| ||||
|
| N/A | |||
|
| ||||
| Limonoid | Niloticin acetate | C32H50O4 | 498.75 g/mol |
|
| Obaculactone or limonin | C26H30O8 | 470.52 g/mol |
| |
| Derivative of obaculactone | N/A | |||
| Obacunone or Obacunoic acid | C26H30O7 | 454.519 g/mol |
| |
| Piscidinol A | C30H50O4 | 474.73 g/mol |
| |
| Rutaevin | C26H30O9 | 486.52 g/mol |
| |
| N–methyltetrahydrocolumbamine | C21H26NO4+ | 356.44 g/mol |
| |
|
| ||||
| Phenolic acid | 2-(p-hydroxyphenyl) -ethanol-1-O- | C9H12O | 136.19 g/mol |
|
|
| ||||
| Quinic acid | 3-O-feruloylquinic acid glucoside | C22H28O15 | 532.45 g/mol |
|
|
| ||||
| Lignan | (+/-)-5,5′-dimethoxylariciresinol-4- | C28H38O13 | 582.6 g/mol |
|
Molecular formula, molecular weight and chemical structures of compounds derived from PCS species (44 compounds).
| Compound derivatives | Compound | Molecular formula | Molecular weight | Chemical structures |
|---|---|---|---|---|
| Alkaloid | Berberine | C20H18NO4+ | 336.37 g/mol |
|
| 8,13-dioxo-14-butoxycanadine | C24H25NO7 | 439.46 g/mol |
| |
| Brucine | C23H26N2O4 | 394.47 g/mol |
| |
| Palmatine | C21H22NO4+ | 352.41 g/mol |
| |
| Phellodendrine | C20H24NO4+ | 342.41 g/mol |
| |
| Magnoflorine | C20H24NO4+ | 342.41 g/mol |
| |
| Jatrorrhizine or Neprotin, 2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol | C20H19NO4 | 337.38 g/mol |
| |
| Lotusine | C19H24NO3+ | 314.40 g/mol |
| |
| (−)-Oblongine | C19H24NO3+ | 314.40 g/mol |
| |
| Isomer-of-magnoflorine | N/A | |||
| Tetrahydrojatrorrhizine | C20H23NO4 | 341.41 g/mol |
| |
| Menisperine | C21H26NO4+ | 356.44 g/mol |
| |
| Columbamine | C20H20NO4+ | 338.38 g/mol |
| |
| Niloticin acetate | C32H50O4 | 498.75 g/mol |
| |
| Piscidinol A | C30H50O4 | 474.73 g/mol |
| |
|
| ||||
| Quinic acid | Chlorogenic acid | C16H18O9 | 354.31 g/mol |
|
| Neo-chlorogenic acid | C16H18O9 | 354.31 g/mol |
| |
| 3-O-feruloylquinic acid | C17H20O9 | 368.34 g/mol |
| |
| 4-O-feruloylquinic acid | C17H20O9 | 368.34 g/mol |
| |
| 5-O-feruloylquinic acid | C17H20O9 | 368.34 g/mol |
| |
|
| ||||
| Hydroxycinnamic acid | Caffeic Acid Methyl Ester | C10H10O4 | 194.19 g/mol |
|
|
| ||||
| Phenolic acid | Ferulic acid | C10H10O4 | 194.19 g/mol |
|
| Methyl ferulate | C11H12O4 | 208.21 g/mol |
| |
| Protocatechuic acid | C7H6O4 | 154.12 g/mol |
| |
|
| ||||
| Lignan | (+/-)-5,5′-dimethoxylariciresinol-4- | C28H38O13 | 582.6 g/mol |
|
| Syringaresinol di-O- | C33H44O18 | 728.70 g/mol |
| |
| (-)-syringaresinol | C22H26O8 | 418.44 g/mol |
| |
|
| ||||
| Coumarin | 3-acetyl-3,4-dihydro-5,6-dimethoxy-1H-2-benzopyran-1-one | C13H14O5 | 250.25 g/mol |
|
|
| ||||
| Paraben | N-propyl paraben | C10H12O3 | 180.20 g/mol |
|
|
| ||||
| Phenolic lactone | Phellolactone | C13H14O8 | 298.25 g/mol |
|
|
| ||||
| Ferulate | N-butyl Ferulate | C14H18O4 | 250.29 g/mol |
|
| Amurenlactone A | C17H20O9 | 368.34 g/mol |
| |
|
| ||||
| Hydroxybenzaldehyde | 4-hydroxybenzaldehyde | C7H8O2 | 124.14 g/mol |
|
|
| ||||
| Phenolic aldehyde | Vanillin | C8H8O3 | 152.15 g/mol |
|
|
| ||||
| Glycoside | 3,4,5-trimetoxyphenol O- | C9H11O3 | 167.18 g/mol |
|
| 2-methoxy-4-(2-propenyl)phenyl-beta-D-glucopyranoside | C16H22O7 | 326.35 g/mol |
| |
| 2-(p-hydroxyphenyl)-ethanol-1-O- | C9H12O | 136.19 g/mol |
| |
| 3, 5-dihydroxybenzoicacid-O-xylopyranosyl-glucopyranoside | C8H8O3 | 152.15 g/mol |
| |
|
| ||||
| Phenolic glycoside | Tachioside | C12H16O8 | 288.25 g/mol |
|
|
| ||||
| Glucoside | Salidroside | C14H20O7 | 300.31 g/mol |
|
| 4-Hydroxybenzyl alcohol | C7H8O2 | 124.14 g/mol |
| |
|
| ||||
| Phenol | Methyl Syringate | C10H12O5 | 212.20 g/mol |
|
|
| ||||
| Dehydrovomifoliol | (6S)-dehydrovomifoliol | C13H18O3 | 222.28 g/mol |
|
| (6R,7aR)-epiloliolide | C11H16O3 | 196.25 g/mol |
| |
Molecular formula, molecular weight and chemical structures of compounds derived from PAC species (34 compounds).
| Compound derivatives | Compound | Molecular formula | Molecular weight | Chemical structures |
|---|---|---|---|---|
| Alkaloid | Berberine | C20H18NO4+ | 336.37 g/mol |
|
| Berberrubine | C19H16NO4+ | 322.34 g/mol |
| |
| Berberastine | C20H18NO5+ | 352.37 g/mol |
| |
| Δ7-Dehydrosophoramine | C15H18N2O | 242.32 g/mol |
| |
| Palmatine | C21H22NO4+ | 352.41 g/mol |
| |
| Tetrahydropalmatine | C21H25NO4 | 355.43 g/mol |
| |
| Phellodendrine | C20H24NO4+ | 342.41 g/mol |
| |
| Jatrorrhizine or Neprotin, 2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol | C20H19NO4 | 337.38 g/mol |
| |
| Lotusine | C19H24NO3+ | 314.40 g/mol |
| |
| Menisperine | C21H26NO4+ | 356.44 g/mol |
| |
|
| ||||
| Isoquinoline alkaloid | Armepavine | C19H23NO3 | 313.40 g/mol |
|
| Demethyleneberberine | C19H18NO4+ | 324.36 g/mol |
| |
|
| ||||
| Limonoid | Kihadanin B | C26H30O9 | 486.52 g/mol |
|
| Niloticin | C30H48O3 | 456.71 g/mol |
| |
| Obaculactone or limonin | C26H30O8 | 470.52 g/mol |
| |
| Obacunone or Obacunoic acid | C26H30O7 | 454.52 g/mol |
| |
|
| ||||
| N-acyl amines | Herculin | C16H29NO | 251.41 g/mol |
|
|
| ||||
| Phenolic acid | Ferulic acid | C10H10O4 | 194.19 g/mol |
|
|
| ||||
| Quinic acid | Quinic acid | C7H12O6 | 192.17 g/mol |
|
| 3-O-feruloyl quinic acid or | C17H20O9 | 368.34 g/mol |
| |
| Chlorogenic acid | C16H18O9 | 354.31 g/mol |
| |
| Sanleng acid | C18H34O5 | 330.47 g/mol |
| |
|
| ||||
| Phytosterol |
| C29H50O | 414.72 g/mol |
|
|
| ||||
| Flavonoid | Amurensin | C26H30O12 | 534.51 g/mol |
|
| Quercetin | C15H10O7 | 302.24 g/mol |
| |
| Phellamurin | C26H30O11 | 518.52 g/mol |
| |
| Phellatin | C26H30O12 | 534.51 g/mol |
| |
| Phellavin | C26H32O12 | 536.53 g/mol |
| |
| 7-dehydrostigmasterol | C29H50O | 414.72 g/mol |
| |
|
| ||||
| Rutaceae | Noricariside | C26H30O12 | 534.51 g/mol |
|
|
| ||||
| Stigmastane | Phellodendroside | C26H30O11 | 518.52 g/mol |
|
|
| ||||
| Monosaccharide | Syringin | C17H24O9 | 372.37 g/mol |
|
| Daucosterol | C34H58O6 | 562.83 g/mol |
| |
|
| ||||
| Ferulate | Amurenamide A | C17H25NO9 | 387.39 g/mol |
|
Molecular formula, molecular weight and chemical structures of compounds derived from PAR species (84 compounds).
| Compound derivatives | Compound | Molecular formula | Molecular weight | Chemical structures |
|---|---|---|---|---|
| Alkaloid | Berberine | C20H18NO4+ | 336.37 g/mol |
|
| Bis-[4-(dimethylamino)phenyl]methanone | C17H20N2O | 268.36 g/mol |
| |
| Dihydrocyclobuxine-D | C25H44N2O | 388.64 g/mol |
| |
| 3,4-Dihydro-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-8-isoquinolinol | C20H24NO4+ | 342.41 g/mol |
| |
| 3,4-Dihydro-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-6-isoquinolinol | C20H17NO5 | 351.36 g/mol |
| |
| 7,8-Dihydroxyrutaecarpine | C18H13N3O3 | 319.32 g/mol |
| |
| 4-Dimethylamino-4 -isopropylbenzene | C18H22NO+ | 268.38 g/mol |
| |
| Evodiamine | C19H17N3O | 303.37 g/mol |
| |
| Palmatine | C21H22NO4+ | 352.41 g/mol |
| |
| Pteleine | C13H13NO3 | 231.25 g/mol |
| |
| (-)-(R)-platydesmin | C15H19NO3 | 261.32 g/mol |
| |
| Noroxyhydrastinine | C10H9NO3 | 191.19 g/mol |
| |
| Chilenine | C19H15NO7 | 369.33 g/mol |
| |
| Phellodendrine | C20H24NO4+ | 342.41 g/mol |
| |
| Magnocurarine | C19H24NO3+ | 314.40 g/mol |
| |
| Magnoflorine | C20H24NO4+ | 342.41 g/mol |
| |
| Jatrorrhizine or Neprotin, 2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol | C20H19NO4+ | 337.38 g/mol |
| |
| 13-Methoxyjatrorrhizine | C21H22NO5+ | 368.41 g/mol |
| |
|
| C13H11NO3 | 229.24 g/mol |
| |
| Canthin-6-one | C14H8N2O | 220.23 g/mol |
| |
| 4-Methoxy-N-methyl-2-quinolone | C11H11NO2 | 189.21 g/mol |
| |
| Candicine | C10H16NO+ | 166.24 g/mol |
| |
| Lotusine | C19H24NO3+ | 314.40 g/mol |
| |
| N-Methylhigenamine-7-O-glucopyranoside | C17H20N2O | 268.36 g/mol |
| |
| N-methylhigenamine-7-O- | N/A | N/A |
| |
| (−)-Oblongine | C19H24NO3+ | 314.40 g/mol |
| |
| Isomer-of-berberine | N/A | |||
| Isomer-of-magnoflorine | ||||
| Isomer-of-palmatine | ||||
| Tetrahydroreticuline | C19H22NO4+ | 328.39 g/mol |
| |
| Tetrahydrojatrorrhizine | C20H23NO4 | 341.41 g/mol |
| |
| Menisperine | C21H26NO4+ | 356.44 g/mol |
| |
| (+) N-methylcorydine | C21H26NO4+ | 356.44 g/mol |
| |
| N-Methyl Tetrahydropalmatine | C22H28NO4+ | 370.47 g/mol |
| |
| N-Methylflindersine | C15H15NO2 | 241.29 g/mol |
| |
| Litcubine | C19H22NO4+ | 328.39 g/mol |
| |
| Hydroxyl-palmatine | C22H22O5 | 366.41 g/mol |
| |
| 11-Hydroxylpalmatine | C21H22NO5+ | 368.41 g/mol |
| |
| 13-Hydroxypalmatine | C21H22NO5+ | 368.41 g/mol |
| |
| 7-Hydroxy-8-methoxydedihydrorutaecarpine | N/A | |||
| Tetrahydropalmatine | C21H25NO4 | 355.43 g/mol |
| |
| 5,8,13,13a-Tetrahydro-2,9,10,11-tetrahydroxy-3-methoxy-7-methyl-6H-dibenzo[a,g]quinolizinium | C21H20NO6+ | 382.39 g/mol |
| |
| Tetrahydroberberine | C20H21NO4 | 339.39 g/mol |
| |
| Xanthoplanine | C21H26NO4+ | 356.44 g/mol |
| |
| N-methylphoebine | C22H26NO5+ | 384.45 g/mol |
| |
| Columbamine | C20H20NO4+ | 338.38 g/mol |
| |
| Dihydroxyl-jatrorrhizine | N/A | |||
| Epiberberine | C20H18NO4+ | 336.37 g/mol |
| |
| Rutecarpine | C18H13N3O | 287.32 g/mol |
| |
| Skimmianine | C14H14NO4+ | 260.27 g/mol |
| |
| Tembetarine | C21H22NO4+ | 352.41 g/mol |
| |
| 8-Oxoberberine | C20H17NO5 | 351.36 g/mol |
| |
| 8-Oxoepiberberine | C20H17NO5 | 351.36 g/mol |
| |
| 8-Oxopalmatine | C21H21NO5 | 367.40 g/mol |
| |
| Oxyberberine | C20H17NO5 | 351.36 g/mol |
| |
| Oxypalmatine | C21H21NO5 | 367.40 g/mol |
| |
|
| ||||
| Limonoid | Obaculactone or limonin | C26H30O8 | 470.52 g/mol |
|
| Obacunone or Obacunoic acid | C26H30O7 | 454.52 g/mol |
| |
| 12 | C26H30O9 | 470.52 g/mol |
| |
| Rutaevin | C26H30O9 | 486.52 g/mol |
| |
| Coniferin | C16H22O8 | 342.34 g/mol |
| |
| Vanilloloside | C14H20O8 | 316.31 g/mol |
| |
|
| ||||
| Phenolic acid | 2-(p-hydroxyphenyl)-ethanol-1-O- | C9H12O | 136.19 g/mol |
|
| 3, 5-dihydroxybenzoicacid-O-xylopyranosyl-glucopyranoside | C8H8O3 | 152.15 g/mol |
| |
| Ferulic acid | C10H10O4 | 194.19 g/mol |
| |
|
| ||||
| Quinic acid | Neochlorogenic acid | C16H18O9 | 354.31 g/mol |
|
| 3-O-feruloyl quinic acid or 5-O-feruloyl quinic acid | C17H20O9 | 368.34 g/mol |
| |
| Chlorogenic acid | C16H18O9 | 354.31 g/mol |
| |
| Methyl 3- | C18H22O9 | 382.37 g/mol |
| |
| Methyl 5-O-feruloylquinate | C8H13O6 | 205.19 g/mol |
| |
| 3-Feruoyl-4-caffeoylquinic acid | C26H26O12 | 530.48 g/mol |
| |
|
| ||||
| Lignan | (+/-)-lyoniresinol | C22H28O8 | 420.46 g/mol |
|
| (+/-)-5,5′- | C28H38O13 | 582.6 g/mol |
| |
| Syringaresinol di-O- | C33H44O18 | 728.70 g/mol |
| |
|
| ||||
| Flavonoid |
| N/A | ||
| Icariside-1 | C26H28O11 | 516.50 g/mol |
| |
| Phellamuretin | C20H20O6 | 356.37 g/mol |
| |
| Phelloside | C31H40CrO17 | 736.64 g/mol |
| |
| Dihydrophelloside | C31H44CrO17 | 740.67 g/mol |
| |
| Isovaleric acid | C5H10O2 | 102.13 g/mol |
| |
| Kaempferol | C15H10O6 | 286.24 g/mol |
| |
| D-glucose | C6H12O6 | 180.16 g/mol |
| |
|
| ||||
| Paraben | N-propyl paraben | C10H12O3 | 180.20 g/mol |
|
|
| ||||
| Glycoside | Sinapyl aldehyde-4-O-beta-D-glucopyranoside | C13H14O6 | 266.25 g/mol |
|
Pharmacological activities of PC and processed PC.
| Pharmacological Activity | Tested Substance |
| Model or sample | Active concentration | Administration (In vivo) | References |
|---|---|---|---|---|---|---|
| Anti-inflammatory effect | PAR extract with voucher specimens |
| BV2 cells (Mouse microglial cell line) | 100 | [ | |
|
| ||||||
| PCC extract |
| 12- | (i) TPA and AA tests: 0.5 mg/ear | Topical application | [ | |
|
| ||||||
| PCC extract with voucher specimens |
| lipopolysaccharides-induced systemic inflammation mice model and macrophage RAW 264.7 cells | 1,10,100 | Oral administration | [ | |
|
| ||||||
| Ethanol extract of PCC with voucher specimens |
| 12-O-tetradecanoyl-phorbol-13-acetate- induced ear edema in mice | 200-400 mg/kg | Administered intragastrically | [ | |
|
| ||||||
| PAR methanol extract with voucher specimens |
| ICR mice and male Wistar rats | IC50: | Oral administration | [ | |
|
| ||||||
| PCC methanol extract with voucher specimens |
| Lipopolysaccharides- induced acute airway inflammation on a mouse model | 100, 200 and 400 mg/kg | Administrated by gavage | [ | |
|
| ||||||
| Demethyleneberberine |
| Acute colitis mice model | 150,300 mg/kg | Oral administration | [ | |
|
| ||||||
| Anti-bacterial effect | Ethanol Extract of PAR; |
| Enterococcus faecium, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa | MIC and MBC: 3.676 mg/ml and 7.353 mg/ml for ethanol extract; | [ | |
|
| ||||||
| PCC extract with voucher specimens |
| Streptococcus. mitis, | 2.5 g/ml | [ | ||
|
| ||||||
| PCC extract |
| Mycoplasma hominis | 0.24-250 mg/ml | [ | ||
|
| ||||||
| Aqueous extract of PCC |
|
| 2.5 or 5 mg/day | Administrated by gavage | [ | |
|
| ||||||
| Berberine in PAR |
| Staphylococcus aureus | 32 to 128 | [ | ||
|
| ||||||
| Berberine in PCS |
| P. aeruginosa | 100 ml | [ | ||
|
| ||||||
| PCC |
| Propionibacterium acnes | MIC50%: 24 | [ | ||
|
| ||||||
| Anti-fungal effect | Berberine hydrochloride, palmatine hydrochloride |
| Microsporum Canis –induced dermatitis in rabbits | MICs 1 mg/ml | Administered through the sterile pipette tip | [ |
|
| ||||||
| Anti-viral effect | Ethanol extract of PAR; |
| African green monkey kidney cells | 6.73 ± 0.87 mg/ml for aqueous extract; | [ | |
|
| ||||||
| Aqueous extract of PAR with voucher specimens |
| H1N1, H5N2, H7N3 or H9N2 infected BALB/c mice | 0.8 | Oral administration | [ | |
|
| ||||||
| Anti-tumor effect | PCS extract with voucher specimens |
| (i) Leukemic cell lines K562 | (i) IC50 of Compound 1: 7.66 ±2.08; | [ | |
|
| ||||||
| PCC extract |
| Prostate cancer cell infested Male BALB/c-nude mice model | 1.6 g/kg per day for 28 days | Administered intragastrically | [ | |
|
| ||||||
| Aqueous extract of PCS with voucher specimens |
| Sarcoma 180 ascites cells implanted Mice model | 2 mg/100g; | Injected intraperitoneally daily for 10 days | [ | |
|
| ||||||
| Anti-gout effect | Compounds of Si-Miao-Wan (containing PCC) |
| Male Sprague-Dawley rats | 1.0 ml/100 g | Oral administration | [ |
|
| ||||||
| PCS extract with voucher specimens |
| Uricase inhibitor potassium oxonate induced male ICR mice model | 480 mg/kg | Oral or intraperitoneal administration | [ | |
|
| ||||||
| Anti-ulcer effect | Ethanol extract of PCC with voucher specimens |
| Acetic acid-induced chronic gastric ulcers on Sprague Dawley rats model | 30 mg/kg/day | Administered intragastrically once a day for seven days. | [ |
|
| ||||||
| Aqueous extract of PCC |
| Ethanol-induced gastric lesions on Male Wistar rats model | 100 mg/kg | Oral administration | [ | |
|
| ||||||
| Anti-oxidant effect | Ethanol extract of PAR; |
| For anti-microbial Enterococcus faecium, Staphylococcus aureus, Streptococcus pyogenes, | 25 mg/ml | [ | |
|
| ||||||
| Phellodendrine isolated from PCC extract |
| AAPH-induced oxidative stress on zebrafish embryo model | 200 | Waterborne exposure | [ | |
|
| ||||||
| Sun screening effect | PCC extract + 50% ethanol |
| PC extract+50% ethanol | 0.5 mg/ml | [ | |
|
| ||||||
| PCC extract |
| UVB lamp inflicted skin lesions on the dorsal of the rats model | 200, 400 or 800 mg/kg, once daily for 11 days | Oral administration | [ | |
|
| ||||||
| Bone-growth effect | PCC extract |
| 72 intact 21-day-old female Sprague–Dawley rats | 100 and 300 mg/kg | Oral administration | [ |
|
| ||||||
| Hemostatic effect | PCC Carbonisatus-carbon dots |
| Mouse tail amputation and liver scratch on male Kunming mice models | 5, 2 and 1 mg | Subcutaneous administration | [ |
|
| ||||||
| Neuroprotective effect | PCC extract with voucher specimens |
| PC-12 cells | 10 and 30 | [ | |
| PCC and PAC extract with voucher specimens |
| PC-12 cells | 0.1 and 1 g/ml for 2 hours | [ | ||
|
| ||||||
| Counter-atopic dermatitis effect | Salt processed PAC extract with voucher specimens |
| 2,4-dinitrochlorobenzene induced skin lesions on the NC/Nga mice model | 200 | Topical administration | [ |
|
| ||||||
| Counter-diabetic nephropathy effect | PAR aqueous extract |
| Streptozotocin-induced diabetes on male Sprague-Dawley rats model | 379 mg/kg | Oral administration | [ |
|
| ||||||
| Berberine |
| Streptozotocin-induced diabetes on male Wistar rats model | 200 mg/kg once a day for 12 weeks | Oral intubation | [ | |
|
| ||||||
| Immunity suppressing effect | Phellodendrine and cyclophosphamide isolated from PCC in saline water |
| ddY mice, BALB/c mice, and Hartlay guinea pigs | (i) 0.1 ml/10 g for mice | Administered intraperitoneally | [ |
|
| ||||||
| Anti-asthmatic effect | n-butyl alcohol extract of PCS with voucher specimens |
| BALB/c mice asthmatic model induced by saline solution | The IC50 of n-butyl alcohol extract of PCS was 12.2 ± 1.3 | intranasally | [ |